Pharmaceutical News & Regulatory Info

Exploring the Advantages of eCTD 4.0

Exploring the Advantages of eCTD 4.0

Celegence2024-12-05T15:45:50+00:00December 5th, 2024|

Pharmaceutical Focus Group Shares Best Practices in Regulatory Publishing and Submissions

Pharmaceutical Focus Group Shares Best Practices in Regulatory Publishing and Submissions

Celegence2024-11-28T12:48:11+00:00November 28th, 2024|

RAPS – Regulatory Readiness & Resources 2024

RAPS – Regulatory Readiness & Resources 2024

Shilpam Rajput2024-11-22T09:56:54+00:00November 22nd, 2024|

Navigate EU Scientific Advice with Confidence – Whitepaper

Navigate EU Scientific Advice with Confidence – Whitepaper

Shilpam Rajput2024-11-19T14:31:33+00:00November 19th, 2024|

Lean Authoring Checklist for Streamlined Regulatory Submissions

Lean Authoring Checklist for Streamlined Regulatory Submissions

Shilpam Rajput2024-11-19T07:14:28+00:00November 18th, 2024|

Ad/Promo Submissions to the FDA: Process, Transition, and Compliance with eCTD

Ad/Promo Submissions to the FDA: Process, Transition, and Compliance with eCTD

Celegence2024-11-25T05:46:10+00:00November 12th, 2024|

Streamlining IDMP Compliance with Effective Master Data Management

Streamlining IDMP Compliance with Effective Master Data Management

Celegence2024-10-31T15:55:48+00:00October 31st, 2024|

EU Clinical Trials – Transition from Directive to Regulation

EU Clinical Trials – Transition from Directive to Regulation

Shilpam Rajput2024-09-18T14:34:59+00:00August 13th, 2024|

Navigating the Complexities of Orphan Drug Designations: A Global Perspective

Navigating the Complexities of Orphan Drug Designations: A Global Perspective

Celegence2024-09-18T14:35:08+00:00August 7th, 2024|

eCTD Module 1 – In Depth Guide for Industry

eCTD Module 1 – In Depth Guide for Industry

Celegence2024-07-18T12:28:34+00:00July 16th, 2024|

Pharmaceuticals Blog

Exploring the Advantages of eCTD 4.0

Exploring the Advantages of eCTD 4.0

Pharmaceutical Focus Group Shares Best Practices in Regulatory Publishing and Submissions

Pharmaceutical Focus Group Shares Best Practices in Regulatory Publishing and Submissions

RAPS – Regulatory Readiness & Resources 2024

RAPS – Regulatory Readiness & Resources 2024

Navigate EU Scientific Advice with Confidence – Whitepaper

Navigate EU Scientific Advice with Confidence – Whitepaper

Lean Authoring Checklist for Streamlined Regulatory Submissions

Lean Authoring Checklist for Streamlined Regulatory Submissions

Ad/Promo Submissions to the FDA: Process, Transition, and Compliance with eCTD

Ad/Promo Submissions to the FDA: Process, Transition, and Compliance with eCTD

Streamlining IDMP Compliance with Effective Master Data Management

Streamlining IDMP Compliance with Effective Master Data Management

EU Clinical Trials – Transition from Directive to Regulation

EU Clinical Trials – Transition from Directive to Regulation

Navigating the Complexities of Orphan Drug Designations: A Global Perspective

Navigating the Complexities of Orphan Drug Designations: A Global Perspective

eCTD Module 1 – In Depth Guide for Industry

eCTD Module 1 – In Depth Guide for Industry

Pharma Resources

Meet Dossplorer

Complimentary Consultation with a Celegence Expert

Our Pharma Services